Ind-Swift Laboratories Ltd. (INDSWFTLAB): Ind-Swift Laboratories Share Price hits fresh 52-week high on NSE
- September 8, 2026
- Posted by: Harsh Piplani
- Category: News
Ind-Swift Laboratories Share Price moved to Rs 396.80, up 8.33% from the previous close, and touched a fresh 52-week high of Rs 402 during the morning session on 08 September 2026 at 9:53 AM IST. The company’s market capitalisation stood at Rs 3,086.27 crore, placing today’s move firmly on the radar of Ind-Swift Laboratories Share Price Today searches and Ind-Swift Laboratories Stock News coverage. The latest Univest data confirms the price event and shows that the stock is trading close to the day’s high after opening at Rs 376.05. What the numbers establish is the move itself; they do not establish a company-specific catalyst. For investors tracking Ind-Swift Laboratories Share Price, the key context today is the fresh 52-week high, the current valuation and the company’s healthcare-sector positioning.
Ind-Swift Laboratories Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 396.8 |
| Previous Close | Rs 366.3 |
| Today's Move | +Rs 30.5 (+8.33%) |
| Open | Rs 376.05 |
| High | Rs 402 |
| Low | Rs 369.2 |
| Turnover | Rs 2.84 crore |
| Market Capitalisation | Rs 3,086.27 crore |
Ind-Swift Laboratories Ltd. (INDSWFTLAB) traded at Rs 396.8 versus the previous close of Rs 366.3, a rise of 8.33%. The stock opened at Rs 376.05, reached a high of Rs 402 and touched a low of Rs 369.2.
Ind-Swift Laboratories Share Price is trading at Rs 396.80 after a gain of Rs 30.50 from the previous close of Rs 366.30. The stock opened at Rs 376.05, moved between Rs 369.20 and Rs 402.00, and the latest print leaves it near the upper end of that range. The 52-week high of Rs 402.00 was also the day’s peak, so the fresh yearly high is a straightforward price event rather than a broad statement about the company’s business. Turnover stood at Rs 2.84 crore, which is a factual traded-value measure for the move. Compared with the previous 52-week high of Rs 402.00, the current price sits just 1.29% below that level. That keeps Ind-Swift Laboratories Share Price in focus for traders and long-only investors watching 52 Week High Stocks and other Stocks in News names on Share Market Today.
Ind-Swift Laboratories Ltd. (INDSWFTLAB) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 3,086.27 crore |
| P/E Ratio | 55.57x |
| P/B Ratio | 2.13x |
| ROE | 24.68% |
| ROCE | 24.24% |
| EPS | Rs 6.59 |
| Book Value Per Share | Rs 171.98 |
| Dividend Yield | 0% |
Ind-Swift Laboratories Ltd. (INDSWFTLAB) fundamental metrics show P/E 55.57x, P/B 2.13x, ROE 24.68%, ROCE 24.24%. These figures provide context only and are not a buy or sell signal.
Ind-Swift Laboratories Ltd. has a market capitalisation of Rs 3086.27 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 55.57x, P/B at 2.13x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 24.68% and ROCE of 24.24%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 6.59, book value per share of Rs 171.98, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 32.47x, median ROE of 11.81%, median ROCE of 13.68%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 55.57x |
| Benchmark Median P/E | 32.47x |
| Benchmark Average P/E | 48.96x |
| Benchmark P/E Range | 3.35x to 654.07x |
| Company P/B Ratio | 2.13x |
| Benchmark Median P/B | 3.04x |
| Company ROE | 24.68% |
| Benchmark Median ROE | 11.81% |
| Company ROCE | 24.24% |
| Benchmark Median ROCE | 13.68% |
| Company Market Capitalisation | Rs 3,086.27 crore |
| Benchmark Median Market Cap | Rs 687.66 crore |
Ind-Swift Laboratories Ltd. (INDSWFTLAB) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Ind-Swift Laboratories Ltd. (INDSWFTLAB) has a P/E ratio of 55.57x, which is above the benchmark median of 32.47x, a difference of +71.14%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Ind-Swift Laboratories Ltd. (INDSWFTLAB) has a ROE of 24.68%, which is above the benchmark median of 11.81%, a difference of +108.98%. Ind-Swift Laboratories Ltd. (INDSWFTLAB) has a ROCE of 24.24%, which is above the benchmark median of 13.68%, a difference of +77.19%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Advanced Enzyme Technologies Ltd. | ADVENZYMES | 3,286.5 | 20.08 | 2 | 11.43 | 15.27 |
| Kwality Pharmaceuticals Ltd. | KPL | 3,417.82 | 43.68 | 9.93 | 22.67 | 24.01 |
| Dishman Carbogen Amcis Ltd. | DCAL | 2,734.3 | 166.29 | 0.41 | 0.06 | 2.31 |
| SMS Pharmaceuticals Ltd. | SMSPHARMA | 3,677.72 | 36.45 | 4.63 | 11.91 | 12.55 |
| Beta Drugs Ltd. | BETA | 2,467.25 | 56.94 | 9.01 | 23.95 | 25.23 |
Ind-Swift Laboratories Ltd. (INDSWFTLAB) has a P/E ratio of 55.57x compared with the displayed peer median of 43.68x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 24.68% compares with a peer median of 11.91% across the companies shown in the table. ROCE stood at 24.24% versus the displayed peer median of 15.27%, providing a capital-efficiency comparison. Ind-Swift Laboratories Ltd. (INDSWFTLAB) has a market capitalisation of Rs 3,086.27 crore. Among the 5 peers shown, 3 have a larger market capitalisation.
Why Investors Are Watching Ind-Swift Laboratories
- Ind-Swift Laboratories Share Price touched a fresh 52-week high of Rs 402.00 in morning trade.
- Ind-Swift Laboratories Share Price is up 8.33% from the previous close of Rs 366.30.
- The company’s market capitalisation stands at Rs 3,086.27 crore.
- P/E is 55.57, while P/B is 2.13 and ROE is 24.68%.
- In the same industry benchmark, ROE and ROCE are both above the median levels.
About Ind-Swift Laboratories
Ind-Swift Laboratories Ltd. is listed on NSE and BSE and is classified in Healthcare within the Pharmaceuticals & Drugs industry. The company is tracked by Univest as part of its stock coverage for Ind-Swift Laboratories Share Price, Ind-Swift Laboratories Company News and broader market update pages. Today’s share price event sits inside that business and sector classification, which is why the stock remains relevant to investors following healthcare names in the Indian stock market.
The latest Univest figures also place Ind-Swift Laboratories Share Price alongside financial metrics such as EPS, book value and revenue trends, helping readers follow both the market update and the company profile in one place. For users who track stock news, this page is designed to keep the Ind-Swift Laboratories Share Price narrative aligned with live market movement and verified company data.
Frequently Asked Questions
Why did Ind-Swift Laboratories Share Price hit a fresh 52-week high?
Ans. Ind-Swift Laboratories Share Price touched Rs 402.00, its fresh 52-week high, after rising 8.33% from the previous close. The price event is confirmed; the numbers do not identify a company-specific catalyst.
What is Ind-Swift Laboratories Share Price today?
Ans. Ind-Swift Laboratories Share Price was Rs 396.80 at the latest update, compared with the previous close of Rs 366.30. It also touched a day high of Rs 402.00 during morning trade.
How much did Ind-Swift Laboratories Share Price move today?
Ans. Ind-Swift Laboratories Share Price rose by Rs 30.50, which translates into an 8.33% gain over the previous close. The stock traded between Rs 369.20 and Rs 402.00 in the session.
What is the market capitalisation of Ind-Swift Laboratories?
Ans. Ind-Swift Laboratories has a market capitalisation of Rs 3,086.27 crore. That places the company above the industry median market cap in the same industry benchmark and below the industry average.
What valuation metrics matter for Ind-Swift Laboratories Share Price?
Ans. Ind-Swift Laboratories Share Price is supported by a P/E of 55.57 and a P/B of 2.13. EPS is Rs 6.59, book value is Rs 171.98 and dividend yield is 0.
How does Ind-Swift Laboratories compare with healthcare peers?
Ans. Compared with listed peers, Ind-Swift Laboratories has a higher P/E than Advanced Enzyme Technologies Ltd. and Unichem Laboratories Ltd., while its ROE and ROCE are stronger than several lower-return comparables in the peer set.
What does the sector benchmark show for Ind-Swift Laboratories?
Ans. In the same industry benchmark, Ind-Swift Laboratories has a P/E above the median, a P/B below the median, and ROE and ROCE above the median. That gives the stock a mixed valuation backdrop.
Where can I track Ind-Swift Laboratories Share Price live?
Ans. You can track Ind-Swift Laboratories Share Price on Univest for live share price updates, market cap, 52-week levels, valuation ratios and peer context. The platform keeps the stock news and company profile together.
Track Ind-Swift Laboratories Share Price on Univest
Use Ind-Swift Laboratories Ltd. (INDSWFTLAB) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Track Ind-Swift Laboratories Share Price on Univest for live share price updates, financial ratios, market capitalisation, 52-week levels, peer comparisons and sector context. Univest also keeps related stock news and company data in one place for quick review.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
